Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
KUNLUN ENERGY
00135
CN Stock MarketDetailed Quotes
Walvax Biotechnology (300142)
- 12.46
- -0.28-2.20%
Market Closed Apr 17 15:00 CST
19.93BMarket Cap112.25P/E (TTM)
12.66High12.39Low352.33KlotVolume12.65Open12.74Prev Close439.89MTurnover2.26%Turnover Ratio112.25P/E (Static)1.60BShares14.6552wk High2.31P/B19.44BFloat Cap9.8152wk Low15.29Limit Up1.56BShs Float96.64Historical High10.19Limit Down2.12%Range %3.53Historical Low0.04Dividend TTM12.49Avg Price206.83KlotAsk0.32%Div Yield TTM100Lot Size140.64KlotBid
Walvax Biotechnology (300142) Income Statement
All
YOY
| (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -14.29%2.42B | -19.73%1.72B | -19.47%1.15B | -22.93%462.26M | -31.41%2.82B | -32.19%2.14B | -33.88%1.43B | -28.02%599.75M | -19.12%4.11B | -14.79%3.16B |
| Operating revenue | -14.29%2.42B | -19.73%1.72B | -19.47%1.15B | -22.93%462.26M | -31.41%2.82B | -32.19%2.14B | -33.88%1.43B | -28.02%599.75M | -19.12%4.11B | -14.79%3.16B |
| Other operating revenue | -67.99%5.72M | ---- | -78.13%3M | ---- | 125.60%17.86M | ---- | 314.92%13.71M | ---- | 3.51%7.92M | ---- |
| Total operating cost | -16.77%2.11B | -15.25%1.49B | -17.22%975.74M | -7.68%426.65M | -19.68%2.53B | -24.34%1.76B | -22.77%1.18B | -30.14%462.15M | -17.18%3.15B | -15.59%2.32B |
| Operating cost | 7.37%615.25M | 10.42%486.53M | 19.65%343.07M | 16.12%131.82M | -4.11%572.99M | -2.36%440.62M | 5.20%286.73M | -9.07%113.52M | -1.95%597.56M | 3.88%451.26M |
| Operating tax surcharges | 7.10%20.22M | 2.92%14.14M | 1.48%9.48M | -14.12%3.58M | -41.05%18.88M | -45.86%13.74M | -52.60%9.34M | -64.08%4.17M | -3.68%32.03M | 1.09%25.37M |
| Operating expense | -12.74%854.09M | -17.27%563.14M | -24.71%376.6M | -21.91%164.34M | -35.59%978.83M | -40.46%680.7M | -36.12%500.22M | -31.01%210.46M | -24.85%1.52B | -22.78%1.14B |
| Administration expense | -6.98%392.13M | 23.06%270.63M | 38.25%170.28M | 14.56%70.78M | 41.64%421.55M | 21.75%219.91M | 1.88%123.17M | 6.10%61.79M | 9.65%297.62M | -2.72%180.63M |
| Financial expense | -16.54%-66.45M | -105.78%-61.84M | -60.27%-44.5M | 27.25%-10.77M | 19.68%-57.02M | 43.50%-30.05M | 21.26%-27.77M | 13.44%-14.8M | -12.72%-70.99M | 1.10%-53.19M |
| -Interest expense (Financial expense) | -126.30%-2.22M | -145.00%-3.45M | -114.61%-927.81K | -88.22%398.29K | 41.72%8.43M | 104.32%7.68M | 133.17%6.35M | 164.41%3.38M | -16.30%5.95M | -31.83%3.76M |
| -Interest Income (Financial expense) | -8.94%-67.24M | -27.46%-58.91M | -30.31%-43.14M | 42.29%-10.57M | 16.85%-61.72M | 12.24%-46.21M | 8.69%-33.11M | -3.64%-18.31M | -6.01%-74.23M | -2.19%-52.66M |
| Research and development | -51.07%291.88M | -49.97%215.7M | -57.90%120.8M | -23.12%66.9M | -23.17%596.54M | -24.82%431.11M | -21.42%286.96M | -51.36%87.02M | -16.77%776.43M | -15.34%573.44M |
| Credit Impairment Loss | -969.83%-148.93M | -306.56%-85.23M | -204.50%-61.33M | -80.74%-17.88M | 119.34%17.12M | 161.51%41.26M | 196.73%58.69M | -1,402.83%-9.89M | -92.81%-88.52M | -186,850.31%-67.08M |
| Asset Impairment Loss | 41.03%-102.73M | -24.61%-122.38M | -95.12%-131.39M | -584.25%-52.05M | -7.11%-174.2M | -681.19%-98.21M | -1,774.78%-67.34M | -8.55%-7.61M | -164.60%-162.64M | 57.44%-12.57M |
| Other net revenue | 36.18%-123.18M | 9.15%-90.15M | -148.27%-164.55M | 36.91%-49.18M | 44.48%-192.99M | -71.49%-99.23M | -599.75%-66.28M | -282.35%-77.95M | -92.27%-347.59M | 54.69%-57.86M |
| Fair value change income | 130.18%29.68M | 197.98%91.8M | 113.16%13.42M | 116.67%14.14M | 58.11%-98.34M | -39.03%-93.69M | -477.86%-102.01M | -7,010.23%-84.82M | -17.77%-234.75M | 68.31%-67.39M |
| Invest income | -49.52%2.54M | -43.16%2.78M | -113.30%-486.06K | -256.95%-136.3K | -29.36%5.03M | -22.20%4.9M | -42.25%3.65M | 132.44%86.84K | -39.69%7.11M | 30.18%6.29M |
| -Including: Investment income associates | -784.04%-889.95K | -983.24%-660.8K | -37,273.99%-486.06K | -256.95%-136.3K | -65.95%130.1K | 117.09%74.82K | 100.32%1.31K | 140.26%86.84K | 135.58%382.09K | 34.76%-437.76K |
| Asset deal income | 104.59%81.07K | 257.69%175.2K | 220.55%130.39K | --29.26K | -113.48%-1.77M | 80.67%-111.1K | -162.80%-108.16K | ---- | -116.55%-827.73K | -1,703.04%-574.86K |
| Other revenue | 62.58%96.19M | -51.33%22.69M | -63.00%15.11M | -72.34%6.71M | -55.18%59.17M | -44.14%46.62M | -38.08%40.83M | -53.05%24.28M | 15.30%132.03M | -23.91%83.46M |
| Operating profit | 94.42%187.95M | -50.94%140.35M | -92.61%13.93M | -122.76%-13.58M | -84.25%96.67M | -63.29%286.08M | -70.19%188.42M | -72.19%59.65M | -44.16%613.97M | -6.00%779.31M |
| Add:Non operating Income | -99.42%731.62K | -99.44%716.56K | -99.46%682.36K | 646,478.11%658.73K | 13,474.13%126.93M | 13,501.19%126.92M | 13,799.10%126.92M | -99.79%101.88 | 619.41%935.06K | 1,413.66%933.18K |
| Less:Non operating expense | -42.28%22.57M | -87.78%4.79M | -93.18%2.57M | -22.67%1.85M | 145.52%39.1M | 551.05%39.22M | 661.34%37.65M | -36.87%2.4M | -45.28%15.92M | -74.18%6.02M |
| Total profit | -9.97%166.11M | -63.54%136.28M | -95.66%12.04M | -125.80%-14.77M | -69.20%184.5M | -51.72%373.79M | -55.78%277.69M | -72.83%57.25M | -44.05%598.98M | -3.92%774.22M |
| Less:Income tax cost | 305.33%40.96M | 41.55%32.77M | -5.16%19.14M | -74.06%4.91M | -88.47%10.1M | -69.93%23.15M | -69.18%20.18M | 52.41%18.94M | -33.72%87.65M | -34.25%76.99M |
| Net profit | -28.23%125.16M | -70.48%103.51M | -102.75%-7.09M | -151.37%-19.68M | -65.89%174.4M | -49.71%350.64M | -54.22%257.52M | -80.68%38.31M | -45.50%511.33M | 1.24%697.23M |
| Net profit from continuing operation | -28.23%125.16M | -70.48%103.51M | -102.75%-7.09M | -151.37%-19.68M | -65.89%174.4M | -49.71%350.64M | -54.22%257.52M | -80.68%38.31M | -45.50%511.33M | 1.24%697.23M |
| Less:Minority Profit | -263.12%-52.58M | -163.56%-59.93M | -157.79%-50.25M | -192.33%-22.33M | -64.93%32.24M | -34.46%94.28M | -18.97%86.96M | -8.09%24.18M | -56.13%91.93M | -8.55%143.85M |
| Net profit of parent company owners | 25.03%177.74M | -36.24%163.44M | -74.69%43.16M | -81.27%2.65M | -66.10%142.16M | -53.67%256.36M | -62.53%170.56M | -91.79%14.13M | -42.44%419.39M | 4.14%553.38M |
| Earning per share | ||||||||||
| Basic earning per share | 24.97%0.1111 | -36.24%0.1022 | -74.39%0.0273 | -80.68%0.0017 | -66.08%0.0889 | -53.64%0.1603 | -62.52%0.1066 | -91.81%0.0088 | -42.34%0.2621 | 2.40%0.3458 |
| Diluted earning per share | 24.97%0.1111 | -36.24%0.1022 | -74.39%0.0273 | -80.68%0.0017 | -66.08%0.0889 | -53.64%0.1603 | -62.52%0.1066 | -91.81%0.0088 | -42.32%0.2621 | 2.49%0.3458 |
| Other composite income | 564.09%213.02M | 106.25M | 39.95M | -45.9M | ||||||
| Other composite income of parent company owners | 564.09%213.02M | --106.25M | --39.95M | ---- | ---45.9M | ---- | ---- | ---- | ---- | ---- |
| Total composite income | 163.18%338.17M | -40.18%209.76M | -87.24%32.86M | -151.37%-19.68M | -74.87%128.5M | -49.71%350.64M | -54.22%257.52M | -80.68%38.31M | -45.55%511.33M | 1.24%697.23M |
| Total composite income of parent company owners | 305.94%390.76M | 5.20%269.69M | -51.27%83.11M | -81.27%2.65M | -77.05%96.26M | -53.67%256.36M | -62.53%170.56M | -91.79%14.13M | -42.51%419.39M | 4.14%553.38M |
| Total composite income of minority owners | -263.12%-52.58M | -163.56%-59.93M | -157.79%-50.25M | -192.33%-22.33M | -64.93%32.24M | -34.46%94.28M | -18.97%86.96M | -8.09%24.18M | -56.13%91.93M | -8.55%143.85M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm